Stanley C. Erck, Director at MAXCYTE, INC. (MXCT), sold 95,378 shares at $3.78 ($358K) on 2024-10-01, disclosed to the SEC on 2024-10-02.
Scheduled sale ($358k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.78 | 26,082 | $99K | 27.6% |
| 2 | $3.78 | 26,082 | $99K | 27.6% |
| 3 | $3.71 | 21,607 | $80K | 22.4% |
| 4 | $3.71 | 21,607 | $80K | 22.4% |
| Total | $3.75 avg | 95,378 | $358K | 100% |
| Filing → |
| MXCT | SELL | 2024-09-05 | $383K | — | Filing → |
| NVAX | SELL | 2021-10-05 | $16.6M | — | Filing → |
| NVAX | SELL | 2021-10-05 | $12.4M | — | Filing → |